Creative Medical Technology Holdings, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Armistice Capital, LLC and Steven Boyd have reported a 4.99% beneficial ownership stake in Creative Medical Technology Holdings, Inc. through a Schedule 13G filing.
NASDAQ
SCHEDULE 13G: Armistice Capital and Steven Boyd Disclose 5.72% Stake in Creative Medical Technology Holdings
Armistice Capital, LLC and Steven Boyd have jointly disclosed a beneficial ownership of 148,000 shares, representing 5.72% of Creative Medical Technology Holdings, Inc.'s common stock.